Akèy › Anemi aplastik
Etid klinik pou Anemi aplastik ap rekrite nan Etazini
26 etid pou Anemi aplastik ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- Washington, DC8 etid
- Baldwin Park, CA5 etid
- Nashville, TN4 etid
- Atlanta, GA4 etid
- Milwaukee, WI4 etid
- Durham, NC4 etid
- New York City, NY4 etid
- St. Louis, MO4 etid
- Philadelphia, PA4 etid
- Birmingham, AL3 etid
- Columbus, OH3 etid
- Detroit, MI3 etid
- Seattle, WA3 etid
- Houston, TX3 etid
- Richmond, VA3 etid
- Memphis, TN3 etid
- Baltimore, MD3 etid
Pa eta
- Alabama3 etid
- Florid4 etid
- Georgia4 etid
- Kalifòni5 etid
- Maryland10 etid
- Michigan3 etid
- Minnesota3 etid
- Missouri4 etid
- New York6 etid
- North Carolina4 etid
- Ohio4 etid
- Pennsylvania5 etid
- Tennessee6 etid
- Texas3 etid
- Virginia3 etid
- Washington3 etid
- Wisconsin4 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
Natural History of Acquired and Inherited Bone Marrow Failure Syndromes
Ap rekriteEtid obsèvasyon
Laj 2 a 99 · Tout sèks · Mizajou Sep 30, 2026 · NCT05012111Pacritinib, a Kinase Inhibitor of CSF1R, IRAK1, JAK2, and FLT3, in Adults and Pediatric Participants 12 Years of Age or Older With Myelodysplastic Syndromes or Myelodysplastic/Myeloproliferative Neoplasms
Ap rekriteFaz 1/2
Laj 12 a 120 · Tout sèks · Mizajou Sep 30, 2026 · NCT06303193Cancer in Inherited Bone Marrow Failure Syndromes
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
1 Day – 100 Years · Tout sèks · Mizajou Sep 30, 2026 · NCT00027274Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies
Ap rekriteFaz 1 bonè
Laj 18 ak plis · Tout sèks · Mizajou Sep 24, 2026 · NCT06398457Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
Ap rekriteFaz 2
Laj 4 a 80 · Tout sèks · Mizajou Sep 22, 2026 · NCT01174108Haploidentical HCT for Severe Aplastic Anemia
Ap rekriteFaz 2
Jiska laj 21 · Tout sèks · Mizajou Sep 16, 2026 · NCT04558736Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome
Ap rekriteFaz 1/2
Laj 4 a 75 · Tout sèks · Mizajou Sep 11, 2026 · NCT03173937Haplo-identical Transplantation for Severe Aplastic Anemia, Hypo-plastic MDS and PNH Using Peripheral Blood Stem Cells and Post-transplant Cyclophosphamide for GVHD Prophylaxis
Ap rekriteFaz 2
Laj 4 a 75 · Tout sèks · Mizajou Sep 8, 2026 · NCT03520647The HOPE Biobank Resource (BMT CTN 2402 HOPE)
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Tout laj · Tout sèks · Mizajou Aug 27, 2026 · NCT07227155A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Jul 6, 2026 · NCT01351545TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children
Ap rekriteFaz 2
Laj 0 a 21 · Tout sèks · Mizajou Jul 1, 2026 · NCT04356469Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jun 22, 2026 · NCT01624805Let's Get REAL: Family Health Communication Tool in Pediatric Stem Cell Transplant and Cellular Therapy
Ap rekrite
Laj 8 ak plis · Tout sèks · Mizajou Jun 4, 2026 · NCT06689800MT2023-20: Hematopoietic Cell Transplant With Reduced Intensity Conditioning and Post-transplant Cyclophosphamide for Severe Aplastic Anemia and Other Forms of Acquired Bone Marrow Failure.
Ap rekriteFaz 2
Laj 0 a 75 · Tout sèks · Mizajou Jun 3, 2026 · NCT06412497Haploidentical Bone Marrow Transplant With Post-Transplant Cyclophosphamide for Patients With Severe Aplastic Anemia
Ap rekriteFaz 2
Laj 1 a 75 · Tout sèks · Mizajou Apr 20, 2026 · NCT02828592Early Initiation of Oral Therapy With Cyclosporine and Eltrombopag for Treatment Naive Severe Aplastic Anemia (SAA)
Ap rekriteFaz 2
Laj 3 a 99 · Tout sèks · Mizajou Mar 9, 2026 · NCT04304820Clinical Trial of Upfront Haploidentical or Unrelated Donor BMT to Restore Normal Hematopoiesis in Aplastic Anemia
Ap rekriteFaz 2
Laj 3 a 75 · Tout sèks · Mizajou Feb 17, 2026 · NCT06517641Alpha/Beta TCD HCT in Patients With Inherited BMF Disorders
Ap rekriteFaz 2
Jiska laj 65 · Tout sèks · Mizajou Jan 30, 2026 · NCT03579875A Reduced-Intensity Conditioning Regimen (Cyclophosphamide, Pentostatin, Anti-thymocyte Globulin) Followed by Haploidentical Hematopoietic Stem Cell Transplant for the Treatment of Patients With Refractory or Recurrent Severe Aplastic Anemia
Ap rekriteFaz 1Volontè an sante akeyi
Jiska laj 75 · Tout sèks · Mizajou Jan 5, 2026 · NCT05757310A Study of Emapalumab for Pediatric Aplastic Anemia
Ap rekriteFaz 2Volontè an sante akeyi
Laj 0 a 25 · Tout sèks · Mizajou Dec 17, 2025 · NCT06430788Exercise Training and NR Supplementation Trial to Improve Fitness in AYA HCT Survivors
Ap rekriteFaz 2
Laj 10 a 30 · Tout sèks · Mizajou Dec 4, 2025 · NCT05194397Two Step Haplo With Radiation Conditioning
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Oct 30, 2025 · NCT05031897Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
Ap rekriteEtid obsèvasyon
Laj 18 a 120 · Tout sèks · Mizajou Oct 27, 2025 · NCT01137643Umbilical Cord Blood Transplantation From Unrelated Donors
Ap rekriteEtid obsèvasyon
2 Months – 75 Years · Tout sèks · Mizajou Oct 10, 2025 · NCT03016806HPC Offered for PRESERVE Expansion
Ap rekriteEtid obsèvasyon
Laj 12 a 80 · Tout sèks · Mizajou Aug 28, 2025 · NCT07145411Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.